Codex Therapeutics

Codex Therapeutics is developing a topical gel from human HSP90 alpha protein to substantially reverse chronic wound healing times.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Parsippany-Troy Hills, NJ, USA
  • Currency USD
  • Founded April 2012
  • Employees 3

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free